Reye's syndrome: current concepts.
Despite greater than 23 years of study, an incomplete understanding of the etiology, epidemiology and pathogenesis of Reye's syndrome persists. Better understanding of the disease has been hampered by the lack of a good animal model on which hypotheses of its pathogenesis could be tested. Human studies indicate that a primary mitochondrial injury may lead to complex metabolic disturbances that produce the observed pathophysiology. Specific directions regarding avenues for future research should pursue two lines: a good animal model still needs to be developed in which the biochemical and morphologic alterations identified in Reye's syndrome are duplicated. This model should include an antecedent viral illness but may not require aspirin exposure as an essential ingredient. With the identification of a satisfactory model, specific questions about the roles of environmental toxins or medications may be answered. Study of noncomatose cases of Reye's syndrome should continue. The specific emphasis should be to delineate what factors (NH3, free fatty acids and dicarboxylic acids) may be implicated in the pathogenesis of the CNS disease with the hopes of devising strategies for more effective treatment of encephalopathy and its attendant morbidity and mortality.
D000293:Adolescent; D000641:Ammonia / Q000097:blood; D000818:Animals; D002648:Child; D004195:Disease Models, Animal; D006501:Hepatic Encephalopathy / Q000378:metabolism; D006801:Humans; D008099:Liver / Q000378:metabolism; D008661:Metabolism, Inborn Errors / Q000150:complications; D012202:Reye Syndrome / Q000453:epidemiology / Q000209:etiology / Q000378:metabolism*; D012459:Salicylates / Q000009:adverse effects; D014118:Toxins, Biological / Q000009:adverse effects; D014481:United States
D012459:Salicylates; D014118:Toxins, Biological; D000641:Ammonia